XanaCIDD Topline Results Webinar Recording

Please see today's webinar at which Actinogen CEO, Dr Steven Gourlay and CMO, Dr Dana Hilt present the top line results from the company's recent clinical trial in cognition and depression. US psychiatry trials expert, Dr Steven Targum MD also joins the presentation and Q&A to discuss the clinical trial results.